AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Amgen (AMGN) Reports Q4 Beat
February 7, 2022 4:59 PM ESTAmgen (NASDAQ: AMGN) reported its Q4 results, with EPS coming in at $4.36, beating the consensus estimate of $4.12. Revenue grew 3% year-over-year to $6.85 billion, slightly missing the consensus estimate of $6.88 billion, driven by increased Other Revenue from the Eli Lilly and Company COVID-19 manufacturing collaboration.
Total... More
Amgen (AMGN) Tops Q4 EPS by 24c
February 7, 2022 4:02 PM ESTAmgen (NASDAQ: AMGN) reported Q4 EPS of $4.36, $0.24 better than the analyst estimate of $4.12. Revenue for the quarter came in at $6.85 billion versus the consensus estimate of $6.88 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
... More